Paracrine control of glucagon secretion in the pancreatic α-cell: Studies involving optogenetic cell activation
No Thumbnail Available
Date
2020-06-12
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
ABSTRACT
The mechanisms controlling glucagon secretion by α-cells in islets of Langerhans
were studied. We generated mice with the light-activated ion channel ChR2
specifically expressed in β-, α-, and δ-cells, and explored the spatio-temporal
relationship between cell activation and glucagon release. In paper I, ChR2 was
expressed in β-cells and photoactivation of these cells rapidly depolarized
neighbouring δ-cell but produced a more delayed effect on α-cells. We showed that
these effects were mediated via electrical signalling from the β- to δ-cells via gapjunction. Once activated, the δ-cells released somatostatin which repolarized the αcells following its intercellular diffusion from the δ- to the α-cells. In paper II we
used a novel antibody for detection of somatostatin, which showed great efficiency
compared with commercially available antibodies. Immunostaining of intact islets
showed an islet-wide network involving α- and δ-cells. Furthermore, we used
immunostaining to compare the islet architecture as pertaining to δ-cell number, and
morphology between islets from healthy human donors and type 2 diabetic donors
and found that the number of δ-cells in type 2 diabetic islets is reduced. In paper
III we expressed ChR2 in α- and δ-cells in two novel mouse models. We showed
that photoactivation of α-cells depolarized the α-cells and evoked action potential
firing, effects that were associated with stimulation of glucagon secretion regardless
of the glucose concentration. In islets exposed to 1 mM glucose, photoactivation of
δ-cells transiently hyperpolarized α-cells, produced a long-lasting inhibition of
glucagon exocytosis and inhibited glucagon secretion at 1 mM glucose but had no
additional inhibitory effect at 6 or 20 mM glucose. The effect of somatostatin was
so strong that it was possible to suppress glucagon secretion by photoactivation of
δ-cells even when measurements were performed using the perfused mouse
pancreas.
Description
Keywords
Type 2 Diabetes, Glucagon, α-Cell, Optogenetics